Dark Forest Capital Management LP Alector, Inc. Transaction History

Dark Forest Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$8.19 - $13.2 $510,793 - $823,257	62,368 New	62,368 $590,000
Q1 2022 May 13, 2022	SELL	$13.02 - $20.78 $4,036 - $6,441	-310 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$19.35 - $25.54 $170,009 - $224,394	-8,786 Reduced 96.59%	310 $6,000
Q3 2021 Nov 12, 2021	BUY	$21.65 - $39.49 $196,776 - $358,924	9,089 Added 129842.86%	9,096 $208,000
Q2 2021 Aug 16, 2021	BUY	$15.5 - $22.48 $108 - $157	7 New	7 $0

165

58.1M

57K

14.9K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $406M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.